Peptide Synthesis Market, by Product (Reagents & Consumables and Equipment (Peptide Synthesizers, Lyophilizers, and Chromatography Equipment)), by Technology (Solid Phase, Liquid Phase, and Hybrid & Recombinant), by Application (Therapeutics (Metabolic Di

Peptide Synthesis Market, by Product (Reagents & Consumables and Equipment (Peptide Synthesizers, Lyophilizers, and Chromatography Equipment)), by Technology (Solid Phase, Liquid Phase, and Hybrid & Recombinant), by Application (Therapeutics (Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Infectious Diseases, and Others), Diagnosis, and Research), by End User (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO), and Academic & Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Peptide synthesis is characterized as the formation of a peptide bond between two amino acids. Peptide synthesis most often occurs by coupling the carboxyl group of the incoming amino acid to the N-terminus of the growing peptide chain. Peptide synthesis is a common approach in even high-throughput biological research and product and drug development.
Market Dynamics
Rising incidence of metabolic disorders such as diabetes is expected to drive the peptide synthesis market growth. For instance, according to an article published by the journal Diabetes Research and Clinical Practice - 'Global and regional diabetes prevalence estimates for 2021 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition in September 2021, 463 million people were estimated to suffer from diabetes in 2021 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.
However, sustainability in synthetic peptide production is expected to hinder the market growth. For instance, according to an article published by the ProteoGenix in November 2021, reports that development of sustainable and efficient catalytic methods is the major challenge in peptide synthesis.
Key features of the study:
This report provides in-depth analysis of the global peptide synthesis market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global peptide synthesis market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth, AAPPTec, and Biotage AB among others
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global peptide synthesis market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide synthesis market.
Detailed Segmentation:
Global Peptide Synthesis Market, By Product:
Reagents & Consumables
Equipment
Peptide Synthesizers
Lyophilizers
Chromatography Equipment
Global Peptide Synthesis Market, By Technology:
Solid Phase
Liquid Phase
Hybrid & Recombinant
Global Peptide Synthesis Market, By Application:
Therapeutics
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Infectious Diseases
Others
Diagnosis
Research
Global Peptide Synthesis Market, By End User:
Pharmaceutical and Biotechnology Companies
Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
Academic and Research Institutes
Global Peptide Synthesis Market, By Region:
North America
By Product:
Reagents & Consumables
Equipment
Peptide Synthesizers
Lyophilizers
Chromatography Equipment
By Technology:
Solid Phase
Liquid Phase
Hybrid & Recombinant
By Application:
Therapeutics
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Infectious Diseases
Others
Diagnosis
Research
By End User:
Pharmaceutical and Biotechnology Companies
Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
Academic and Research Institutes
By Country:
U.S.
Canada
Latin America
By Product:
Reagents & Consumables
Equipment
Peptide Synthesizers
Lyophilizers
Chromatography Equipment
By Technology:
Solid Phase
Liquid Phase
Hybrid & Recombinant
By Application:
Therapeutics
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Infectious Diseases
Others
Diagnosis
Research
By End User:
Pharmaceutical and Biotechnology Companies
Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
Academic and Research Institutes
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product:
Reagents & Consumables
Equipment
Peptide Synthesizers
Lyophilizers
Chromatography Equipment
By Technology:
Solid Phase
Liquid Phase
Hybrid & Recombinant
By Application:
Therapeutics
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Infectious Diseases
Others
Diagnosis
Research
By End User:
Pharmaceutical and Biotechnology Companies
Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
Academic and Research Institutes
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product:
Reagents & Consumables
Equipment
Peptide Synthesizers
Lyophilizers
Chromatography Equipment
By Technology:
Solid Phase
Liquid Phase
Hybrid & Recombinant
By Application:
Therapeutics
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Infectious Diseases
Others
Diagnosis
Research
By End User:
Pharmaceutical and Biotechnology Companies
Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
Academic and Research Institutes
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product:
Reagents & Consumables
Equipment
Peptide Synthesizers
Lyophilizers
Chromatography Equipment
By Technology:
Solid Phase
Liquid Phase
Hybrid & Recombinant
By Application:
Therapeutics
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Infectious Diseases
Others
Diagnosis
Research
By End User:
Pharmaceutical and Biotechnology Companies
Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
Academic and Research Institutes
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product:
Reagents & Consumables
Equipment
Peptide Synthesizers
Lyophilizers
Chromatography Equipment
By Technology:
Solid Phase
Liquid Phase
Hybrid & Recombinant
By Application:
Therapeutics
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Infectious Diseases
Others
Diagnosis
Research
By End User:
Pharmaceutical and Biotechnology Companies
Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
Academic and Research Institutes
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
GenScript Biotech Corporation.*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Merck KGaA
ThermoFisher Scientific Inc.
Syngene
Lonza
Novo Nordisk A/S
Bachem Holding AG
Gyros Protein Technologies
Creative Diagnostics
CEM Corporation
PuroSynth
AAPPTec
Biotage AB
“*” marked represents similar segmentation in other categories in the respective section.